Unusually long-term responses to vemurafenib in BRAF V600E mutated colon and thyroid cancers followed by the development of rare RAS activating mutations

DOI: 10.1080/15384047.2018.1480289

Keywords: RAF V600E, RAS, vemurafenib, colon cancer, thyroid cancer

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text